SAN DIEGO–( COMPANY CORD)– Onego Biography, a Finnish-U.S. food active ingredient firm, introduced the entry of its Usually Identified as Safe (GRAS) notice to the united state Fda (FDA) for its non-animal ovalbumin, created via accuracy fermentation making use of Trichoderma reesei, and branded as Bioalbumen ®. This landmark notes a vital action towards bringing the initial non-animal egg healthy protein with an amino acid series the same to the all-natural healthy protein, to the worldwide food m.
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/onego-bio-submits-formal-gras-notification-to-fda-for-bioalbumen/
